Table 4.
Distribution of papers on clozapine and other atypical antipsychotic drugs in the world’s 12 most productive countries in biomedicine and health sciences for the period 1970–2013.
| Rank | Country * | % * | Psy-Neurol ** (%) | Clozapine | Clozapine/Psy-Neurol | AADs *** (%) | AADs/Psy-Neurol |
|---|---|---|---|---|---|---|---|
| 1 | USA | 24.91 | 36.16 | 24.32 | 0.14 | 24.08 | 0.34 |
| 2 | UK | 6.69 | 9.31 | 6.27 | 0.14 | 4.69 | 0.26 |
| 3 | Japan | 5.88 | 6.59 | 0.98 | 0.03 | 3.97 | 0.31 |
| 4 | Germany | 5.81 | 7.64 | 5.40 | 0.15 | 5.11 | 0.34 |
| 5 | France | 4.17 | 5.13 | 2.90 | 0.12 | 2.03 | 0.20 |
| 7 | Italy | 3.56 | 4.67 | 3.54 | 0.16 | 3.61 | 0.39 |
| 8 | Canada | 3.24 | 4.85 | 3.79 | 0.16 | 3.63 | 0.38 |
| 6 | China | 3.22 | 2.60 | 1.42 | 0.11 | 1.91 | 0.37 |
| 9 | Spain | 2.14 | 2.44 | 1.39 | 0.12 | 2.68 | 0.56 |
| 10 | Australia | 2.10 | 2.80 | 2.76 | 0.21 | 1.55 | 0.28 |
| 11 | Netherlands | 2.02 | 2.68 | 1.89 | 0.15 | 1.41 | 0.27 |
| 12 | India | 1.73 | 1.37 | 1.62 | 0.25 | 1.65 | 0.62 |
Psy-Neurol (area of focus in neurology and psychiatry); AADs (atypical antipsychotic drugs); * The world’s 12 most productive countries in biomedicine and health sciences for the period 1970–2013; ** Their productivity in the discipline of Psychiatry and Neurology; *** Risperidone, olanzapine, ziprasidone, quetiapine, sertindole, aripiprazole, paliperidone, amisulpride, zotepine, asenapine, iloperidone, lurasidone, perospirone and blonanserin; Total documents 1970–2013: 24,347,068; Total documents in the neurology and psychiatry area 1970–2013: 2,585,768.